Mutational analysis of death receptor genes Fas, TRAILR1 and TRAILR2 in prostate carcinomas

APMIS

Volumn 118, Issue 8, 2010, Pages 615-616

  Park, Sang Wook ^a   Kim, Min Sung ^a   Lee, Ji Youl ^a   Yoo, Nam Jin ^a   Lee, Sug Hyung ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

DEATH RECEPTOR 4; DEATH RECEPTOR 5; FAS ANTIGEN;

APOPTOSIS; CANCER STAGING; CELL SURVIVAL; GENE MUTATION; HUMAN; LETTER; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROSTATECTOMY; PROTEIN ANALYSIS; PROTEIN EXPRESSION;

ADULT; AGED; ANTIGENS, CD95; APOPTOSIS; HUMANS; MALE; MIDDLE AGED; MUTATION; PROSTATIC NEOPLASMS; RECEPTORS, TNF-RELATED APOPTOSIS-INDUCING LIGAND; RECEPTORS, TUMOR NECROSIS FACTOR;

EID: 77954721990     PISSN: 09034641     EISSN: 16000463     Source Type: Journal    
DOI: 10.1111/j.1600-0463.2010.02628.x     Document Type: Letter

References (8)

1. Reed JC. Mechanisms of apoptosis. Am J Pathol 2000 39 : 1415 1430.
2. Lee SH, Shin MS, Park WS, Kim SY, Kim HS, Han JY, et al. Alterations of Fas (Apo-1/CD95) gene in non-small cell lung cancer. Oncogene 1999 18 : 3754 3760.
3. Lee SH, Shin MS, Park WS, Kim SY, Dong SM, Pi JH, et al. Alterations of Fas (APO-1/CD95) gene in transitional cell carcinomas of urinary bladder. Cancer Res 1999 59 : 3068 3072.
4. Shin MS, Kim HS, Lee SH, Park WS, Kim SY, Park JY, et al. Mutations of tumor necrosis factor-related apoptosis-inducing ligand receptor 1 (TRAIL-R1) and receptor 2 (TRAIL-R2) genes in metastatic breast cancers. Cancer Res 2001 61 : 4942 4946.
5. Lee SH, Shin MS, Kim HS, Lee HK, Park WS, Kim SY, et al. Somatic mutations of TRAIL-receptor 1 and TRAIL-receptor 2 genes in non-Hodgkin's lymphoma. Oncogene 2001 20 : 399 403.
6. Lee SH, Shin MS, Kim HS, Lee HK, Park WS, Kim SY, et al. Alterations of the DR5/TRAIL receptor 2 gene in non-small cell lung cancers. Cancer Res 1999 59 : 5683 5686.
7. Takayama H, Takakuwa T, Dong Z, Nonomura N, Okuyama A, Nagata S, et al. Fas gene mutations in prostatic intraepithelial neoplasia and concurrent carcinoma: analysis of laser capture microdissected specimens. Lab Invest 2001 81 : 283 288.
8. Kim SY, Song SY, Kim MS, Lee JY, Lee HM, Choi HY, et al. Immunohistochemical analysis of Fas and FLIP in prostate cancers. APMIS 2009 117 : 28 33.